Latest News for: Information stockholm

Edit

Third Party Withdraws Appeal Related to Cantargia Patent

Pharmiweb 16 May 2024
LUND, SWEDEN / ACCESSWIRE / May 16, 2024 / Cantargia (STO.CANTA) (Cantargia AB; Nasdaq Stockholm ... For further information, please contact ... The information ... Cantargia is listed on Nasdaq Stockholm (ticker.
Edit

Vicore Expands and Strengthens its Board of Directors

Pharmiweb 14 May 2024
He also served on the boards of Wilson Therapeutics (Nasdaq Stockholm ... For further information, please contact. ... This information was submitted for publication on May 14, 2024, at 08.00 CET ... For more information, see www.vicorepharma.com.
Edit

MGI - Media and Games Invest SE Proposal from MGI’s Nomination Committee (M8G)

ACCESSWIRE 08 May 2024
Stockholm, May 08, 2024 The Nomination Committee of MGI - Media and Games Invest SE Responsible parties The information in this release has been made public through the agency of the responsible ...
Edit

IRLAB Publishes Interim Eeport for the Period January-March 2024

Pharmiweb 08 May 2024
We have just received the information that the pharmaceutical authorities have approved our application to conduct the study, so we estimate that the study will be able to start during the month of May ... For more information.
Edit

Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)

Pharmiweb 07 May 2024
STOCKHOLM, SE / ACCESSWIRE / May 7, 2024 / Vicore Pharma Holding (STO.VICO) ... Stockholm, 7 May 2024 ... For further information, please contact. ... The company's shares (VICO) are listed on Nasdaq Stockholm's main market.
Edit

Invitation to Presentation of Cantargia's Interim Report for Q1 2024 on May 21 at 3.00 p.m. CEST

Pharmiweb 07 May 2024
LUND, SWEDEN / ACCESSWIRE / May 7, 2024 / Cantargia (STO.CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm.CANTA) will publish the company's interim report for the first quarter 2024 on Tuesday, May 21, 2024, at 07.00 a.m.
Edit

IRLAB Enters a Development Collaboration for IRL757 as a Novel Treatment for Apathy

Pharmiweb 07 May 2024
For more information ... This information is information that IRLAB Therapeutics is obliged to make public pursuant to the EU Market Abuse Regulation ... Headquartered in Sweden, IRLAB is listed on Nasdaq Stockholm (IRLAB A).
Edit

IRLAB: Invitation to the Interim Report for Q1 2024 Presentation and Webcast

Pharmiweb 06 May 2024
For more information ... Headquartered in Sweden, IRLAB is listed on Nasdaq Stockholm (IRLAB A). For more information, please visit www.irlab.se.
Edit

IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of the Drug Candidate IRL757

Pharmiweb 06 May 2024
For more information. ... Headquartered in Sweden, IRLAB is listed on Nasdaq Stockholm (IRLAB A). For more information, please visit www.irlab.se.
Edit

Elekta further strengthens its Elekta ONE software suite with acquisition of Philips treatment planning patent portfolio

Pharmiweb 03 May 2024
STOCKHOLM – Elekta (EKTA-B.ST) announces the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent portfolio ... For further information, please contact. ... on Nasdaq Stockholm.
Edit

Interim Report January-March 2024

Pharmiweb 03 May 2024
For further information, please contact. ... This information was submitted for publication on May 3 2024 at 08.00 CET ... The company's shares (VICO) are listed on Nasdaq Stockholm's main market. For more information, see www.vicorepharma.com.
Edit

IRLAB publishes Annual Report for 2023

Pharmiweb 29 Apr 2024
For more information ... This information is information that IRLAB Therapeutics is obliged to make public pursuant to the Securities Markets Act ... Headquartered in Sweden, IRLAB is listed on Nasdaq Stockholm (IRLAB A).
Edit

Cantargia Publishes Annual Report for 2023

Pharmiweb 18 Apr 2024
Cantargia (Cantargia AB; Nasdaq Stockholm.CANTA) today announced that the annual report for 2023 has been published ... For further information, please contact. ... Cantargia is listed on Nasdaq Stockholm (ticker.
Edit

Notice of Annual General Meeting in Cantargia AB (publ)

Pharmiweb 18 Apr 2024
When giving notice, the shareholder shall state name, personal or corporate registration number, address, telephone number and the number of any accompanying assistant(s) (maximum two assistants) as well as information about any proxy.
Edit

Cantargia Publishes New Data on the CAN10 Antibody, Detailing its Interaction with IL1RAP and Functional Inhibition

Pharmiweb 17 Apr 2024
For further information, please contact ... Cantargia is listed on Nasdaq Stockholm (ticker ... More information about Cantargia is available at www.cantargia.com.
×